Courage in Innovation: COI’s President and CEO, Jay Lichter, Named to...
PharmaVOICE has named Jay Lichter, Ph.D., president and CEO of COI Pharmaceutical, to the magazine’s 2016 list of 100 outstanding professionals in the life-sciences industry. Dr. Lichter was chosen as...
View ArticleJay Lichter Shares Words of Advice in San Diego Business Journal: What to...
Pitching ideas to investors is an intense process that can confound even the most ambitious entrepreneur. Throughout his career, Jay Lichter, Ph.D., has been on both sides of the investment table....
View ArticleAvelas Biosciences Completes $20 Million Series C Financing
SAN DIEGO, August 18, 2016 – Avelas Biosciences, Inc., a clinical stage oncology-focused company dedicated to improving cancer patient care from diagnosis through treatment, today announced it has...
View ArticleAvelas Biosciences Completes Patient Enrollment for AVB-620 Phase 1b Clinical...
SAN DIEGO, Sept. 8, 2016 — Avelas Biosciences, Inc., a clinical stage oncology-focused company dedicated to improving cancer patient care from diagnosis through treatment, today announced the...
View ArticleFortis Therapeutics Closes $18 Million Series A Financing to Advance New...
SAN DIEGO, September 27, 2016 – Fortis Therapeutics, Inc., a new immuno-oncology biotech, today announced the close of an $18 million Series A financing. The investment was led by Avalon Ventures and...
View ArticleAristaMD Expands eConsult Services System Wide at North County Health...
Expansion Based on Successful Pilot that Improved Timely Access to Specialty Care SAN DIEGO, Oct. 11, 2016 – AristaMD, a technology-enabled service company providing a suite of electronic specialist...
View ArticleWhat Makes A Successful Biotech Company?
Bradley Fikes, a veteran reporter at The San Diego Union-Tribune, has been covering the biotech industry for 26 years. During that time, he has talked with countless scientists and entrepreneurs who...
View ArticleIn the news: Fortis sets out to treat late-stage prostate cancer
Fortis Therapeutics debuted in September with an $18 million Series A financing to develop a novel antibody drug conjugate therapeutic that targets metastatic castrate-resistant prostate cancer....
View ArticleAvelas Presents Phase 1b Clinical Trial Data for AVB-620 at 2016 San Antonio...
SAN DIEGO, Dec. 8, 2016 — Avelas Biosciences, Inc., a clinical stage oncology-focused company dedicated to improving cancer patient care from diagnosis through treatment, today presented clinical trial...
View ArticlePCOM Primary Care Innovation Fund Selects AristaMD for Its First Investment
Investment in eConsult Platform that Expedites PCP Access to Specialty Expertise Marks First for Fund PHILADELPHIA and SAN DIEGO – January 4, 2017 – AristaMD, a digital health company focused on...
View ArticleLooking Back on 2016: A Year of Firsts, Financings, and Fun
Reflection is an important part of any journey. So, we wanted to take a short moment in our focused pursuit of developing life-changing medicines and technologies to reflect on 2016. This year has...
View ArticleAristaMD Partners with San Mateo Medical Center on Customized Clinical Workup...
Platform Increases Efficiency in Specialist Referral Process and Lowers Cost SAN DIEGO – January 9, 2017 – AristaMD, a digital health company focused on improving the specialty referral process, today...
View ArticleWhat does COI look for in an investment opportunity?
Identifying the right project for investment is fundamental to developing a successful life sciences company. What is the secret to selecting technologies and investment opportunities that become part...
View ArticleCOI’s Focus on Rare Disease
There are more than 7,000 rare diseases affecting millions of people all over the globe. These diseases, which tend to be genetic, are designated rare when a disorder affects fewer than 200,000...
View ArticleJay Lichter, Ph.D. to Speak at Xconomy Forum: Human Impact of Innovation
Xconomy is organizing a forum to address the questions: What are the major innovations that will have the biggest overall impact on humans—on people’s lives, comfort, health, and security—and what role...
View ArticleClik here to view.
C is for Community
Going beyond the science to create an environment that fosters health and wellness Following an unusually wet winter in Southern California, San Diego is now experiencing one of the biggest floral...
View ArticleCHCACT Selects AristaMD as Their eConsult Enterprise Partner to Drive...
AristaMD’s Smart Care Platform to deliver expanded patient access to specialist care, enhancing cost-savings and health outcomes SAN DIEGO, May 9, 2017 /PRNewswire/ — AristaMD, innovative provider of...
View ArticleClik here to view.
A Minute for Celiac Disease
May is dedicated to raising awareness for celiac disease, and the advocacy group, Beyond Celiac, would like everyone to take 60 seconds to learn more about this invisible illness. What is celiac...
View ArticleBIO 2017: Transforming Local Innovation into Global Innovation
Each year biotechnology and pharmaceutical industry leaders come together to discuss and learn about current trends and build business relationships. This year the convention will be held in San Diego...
View ArticleWhat Others Can Learn from COI’s Approach to Cost-Efficient Drug Development...
The Bio Report chats with COI President and CEO, Jay Lichter, Ph.D., to discuss COI’s unique “incubator” approach to discovering and developing new therapeutics. With the increasing costs of drug...
View Article